ME/CFS patients were significantly more sensitive to the transient hemodynamic effects of CRFR2 stimulation than healthy subjects in a prior trial, supporting the hypothesized CRFR2 upregulation. This evidence concerns the gene CRHR2 and myalgic encephalomeyelitis/chronic fatigue syndrome.